EGFR and non-small cell lung carcinoma: Using unbiased gene-expression profiles of cells, their study revealed that over-expression of these EGFR-bypass genes plays a critical role in EGFR-independent activation of the MEK-ERK and PI3K-AKT signaling pathways in EGFR-mutant NSCLC cells.